ICD-10 code Q93.1: Whole chromosome monosomy, mosaicism explained

Key Takeaways

ICD-10 code Q93.1 describes whole chromosome monosomy, mosaicism (mitotic nondisjunction) and is a billable ICD-10-CM code valid for HIPAA-covered transactions

Q93.1 sits within parent code Q93 (Monosomies and deletions from the autosomes), part of block Q90-Q99 (Chromosomal abnormalities, not elsewhere classified), within chapter Q00-Q99 (Congenital malformations, deformations and chromosomal abnormalities)

Non-mosaic (meiotic) whole-chromosome monosomy does not code to Q93.1; use Q93.0 (Whole chromosome monosomy, nonmosaicism) instead, based on the documented cytogenetic findings

Q93.1 is on the CMS present-on-admission (POA) exempt code list, so coders shouldn’t default to a routine “Y” POA indicator the way they would for most congenital diagnoses

ICD-10 code Q93.1 is the billable code for whole chromosome monosomy, mosaicism (mitotic nondisjunction): a congenital condition where an entire autosome is missing from a portion of a patient’s cells, while the remaining cells carry a normal chromosome count.

The mosaic form is easy to mix up with its nonmosaic sibling. Q93.1 applies only when cytogenetics document mosaicism. The nonmosaic (meiotic) form of the same whole-chromosome loss is a separate code, Q93.0, and the two aren’t interchangeable. Getting that distinction right protects reimbursement and reduces payer queries, a principle that carries across the wider Q00-Q99 chapter, including codes like Q75.8.

ICD-10 code Q93.1: Definition and billable status

ICD-10 code Q93.1 is a valid, billable ICD-10-CM code. Its official description is Whole chromosome monosomy, mosaicism (mitotic nondisjunction). The code is effective for the current fiscal year and is classified as a congenital malformation.

It’s valid for submission on HIPAA-covered transactions and doesn’t require a more specific sibling code to be billable. Q93.1 is itself the terminal code within its grouping for mosaic whole-chromosome monosomy. The nonmosaic (meiotic) form of the same whole-chromosome loss is captured separately by sibling code Q93.0.

Q93.1 code details at a glance

The table below covers the reference fields coders need when verifying Q93.1 for submission. Figures reflect the current ICD-10-CM fiscal year release as maintained by CMS ICD-10 codes.

Clinical description: Whole chromosome monosomy, mosaicism

Monosomy refers to the presence of only one copy of a chromosome instead of the normal paired set. In a typical diploid human genome, autosomes appear in pairs, one from each parent. When a whole chromosome is absent from a pair, the result is autosomal monosomy.

This is what ICD-10 code Q93.1 captures: a mosaic, whole-chromosome loss affecting one of the autosomes, arising from mitotic (post-zygotic) nondisjunction. Only a proportion of the patient’s cells are missing the chromosome; the rest carry a normal count.

Complete, nonmosaic autosomal monosomy is almost always lethal in early gestation. That’s why the mosaic form is the presentation most often seen in live-born individuals and in prenatal cytogenetic findings: the normal cell line existing alongside the monosomic line buffers the effect enough for a pregnancy to continue. Monosomy 21 mosaicism is among the most clinically documented examples.

Cytogenetic confirmation via karyotype or chromosomal microarray analysis is required before applying this code. Practices managing protecting patient health records in genetics settings should ensure cytogenetic reports are scanned and attached to the patient’s record before submitting this code on a claim.

• Mechanism: Mitotic (post-zygotic) nondisjunction occurring after fertilization, producing two or more cell lines in the same individual — one with a missing autosome and one with a normal chromosome count
• Affected chromosomes: Any autosome; monosomy 21 mosaicism is the most documented example in live-born cases
• Mosaicism distinction: A mosaic presentation means the monosomy is present in only a proportion of analyzed cells, not uniformly across all of them — this is the distinction that separates Q93.1 from the nonmosaic presentation coded to Q93.0
• Confirmation required: Cytogenetic karyotype or chromosomal microarray analysis documenting two or more cell lines, typically written in mosaic karyotype notation (for example, 45,XX,-21/46,XX)

ICD-10-CM hierarchy and the Q93 code block

Understanding where Q93.1 sits in the ICD-10-CM hierarchy helps coders select the right code and avoid reporting a non-specific parent code when a more defined child code is available. The CDC/NCHS ICD-10-CM web tool provides the full tabular list with hierarchy navigation. The structure relevant to Q93.1 is:

Q93 itself is not billable. Coders must always report to the highest level of specificity available. When documentation supports a whole-chromosome mosaic monosomy, Q93.1 is the appropriate terminal code. Use Q93.0 instead when the finding is nonmosaic.

Reporting the parent Q93 when a more specific child code is documented is a specificity error that payers may flag on review. Verify current codes via the WHO ICD-10 browser for international equivalents.

Coding guidelines for ICD-10 code Q93.1

Applying Q93.1 correctly involves more than matching a description. The ICD-10-CM Official Guidelines for Coding and Reporting, maintained by CMS and updated annually, govern sequencing, POA assignment, and use of additional codes. Practice management software like Pabau, through its claims management tools, can flag congenital condition encounters for documentation review before submission.

• Principal vs. secondary diagnosis: When a patient presents specifically for evaluation or management of the chromosomal condition, Q93.1 is sequenced as the principal diagnosis. When it is an underlying condition complicating another presenting problem, it is sequenced as a secondary code.
• POA indicator: Most congenital conditions are present on admission by definition and assigned a POA indicator of “Y”. Q93.1 is an exception: it’s on the CMS present-on-admission exempt code list, so coders should follow payer-specific POA-exempt guidance rather than defaulting to “Y” for this code.
• Additional codes: Document and code any associated manifestations separately. A patient with Q93.1 who also has a congenital heart defect should have that defect coded additionally (e.g., Q20-Q28).
• Z-code pairings: Genetic counseling or screening encounters may warrant Z13.79 (encounter for other screening for genetic and chromosomal anomalies) or Z13.71 (encounter for nonprocreative screening for genetic disease carrier status), depending on context. Confirm the encounter type before adding supplementary Z codes.
• Excludes notes: Review the tabular list carefully. Q93 has includes/excludes notes that distinguish autosomal monosomies from sex chromosome monosomies (e.g., Turner syndrome Q96.x).

The same logic applies across specialties, whether coding Q93.1 or another congenital anomaly such as Q42.0: document the cytogenetic or clinical basis, sequence by encounter purpose, and use additional codes for any separately identifiable conditions.

Applicable clinical conditions

Q93.1 applies when documented cytogenetics confirm a mosaic, whole-chromosome autosomal monosomy — a normal (or otherwise abnormal) cell line alongside the monosomic line. The most relevant clinical scenarios include:

• Monosomy 21, mosaicism: Some analyzed cells lack one copy of chromosome 21 while others show a normal chromosome count, typically written as 45,XX,-21/46,XX (or 45,XY,-21/46,XY). Presentation ranges from developmental delay and congenital anomalies to a milder phenotype, depending on the proportion of affected cells. This mosaic pattern is markedly more compatible with survival than the complete, nonmosaic form.
• Other autosomal monosomies, mosaicism: Nonmosaic monosomy of chromosomes other than 21 is almost always lethal in early gestation, so live-born or ongoing cases documented outside chromosome 21 are typically mosaic. Documentation of a confirmed mosaic presentation at any gestational age supports Q93.1.
• Prenatal cytogenetic findings: When a prenatal karyotype or chromosomal microarray confirms mosaic whole-chromosome monosomy, Q93.1 may be applicable for the prenatal encounter coding depending on payer policy, though confined placental mosaicism should be ruled out or noted where relevant. Code the encounter as a confirmed finding if the provider has documented the diagnosis.

Practices providing genetic services or developmental pediatrics benefit from digital intake forms that capture cytogenetic report details at the point of care, reducing the risk of coding from incomplete documentation.

The same principle extends to other specialty intake workflows: OB-GYN EMR software and mental health EMR software show how condition-specific documentation tools support accurate coding across disciplines.

Mosaicism and Q93.1: What coders need to know

This is the most common coding confusion in the Q93 block. Mosaicism means the chromosomal abnormality is present in only a proportion of cells, not uniformly across all analyzed cells.

ICD-10 code Q93.1 specifically describes this mosaic presentation, arising from mitotic (post-zygotic) nondisjunction. The nonmosaic presentation is a distinct clinical and coding entity, captured by Q93.0: the missing chromosome is absent from every analyzed cell, consistent with meiotic nondisjunction.

When cytogenetics document a nonmosaic pattern, coders should report Q93.0, not Q93.1. Don’t confuse this mosaic-versus-nonmosaic split with Q93.3 through Q93.9, which cover an entirely different category of finding: partial deletions and structural rearrangements of specific chromosomes.

Q93.3, for example, is deletion of the short arm of chromosome 4, seen in Wolf-Hirschhorn syndrome, not a version of the mosaic-versus-nonmosaic distinction. That split for a missing whole chromosome is handled entirely by Q93.1 and Q93.0.

Consistent clinical documentation best practices help ensure the cytogenetic report’s exact language, mosaic or nonmosaic, meiotic or mitotic, translates cleanly into code selection.

Related ICD-10-CM codes and cross-references

Accurate code selection for chromosomal monosomy requires familiarity with adjacent codes that are commonly confused with Q93.1. The AAPC Codify ICD-10-CM lookup provides searchable access to the full Q90-Q99 block. Cross-referencing the tabular list for Excludes1 and Excludes2 notes is essential before assigning Q93.1, the same discipline that applies to any complex diagnostic guide, including R54.

Streamline your chromosomal disorder claims with Pabau

Pabau's claims management tools help genetics and pediatric practices reduce coding errors, track submission status, and document cytogenetic findings accurately before they reach the payer.

Book a demo

Conclusion

ICD-10 code Q93.1 is a straightforward billable code when the clinical documentation is right: a confirmed, mosaic, whole-chromosome autosomal monosomy arising from mitotic nondisjunction.

The risk points are mosaicism confusion (use Q93.0 for the nonmosaic, meiotic form instead of Q93.1), unspecified coding (avoid Q93.9 when either code is supported), missing additional codes for associated conditions, and POA assignment (Q93.1 is POA-exempt, not a routine “Y”).

Pabau’s claims management tools help practices track complex congenital disorder submissions and flag incomplete documentation before claims reach the payer. To see how it works in a genetics or pediatric setting, book a demo with the Pabau team.

Continue your research

Need a reference for another commonly confused diagnosis code? R61 walks through generalized hyperhidrosis and how it differs from the focal L74.5x subcodes.

Billing a procedure alongside a congenital diagnosis? CPT 15101 covers split-thickness autograft billing and the pairing rule coders miss most often.

Want to improve coding documentation workflows? Healthcare practitioner form is a ready-to-use template for capturing medical and psychiatric history at admission.

Frequently asked questions